Observations placeholder
Mesna
Identifier
019516
Type of Spiritual Experience
Background
A description of the experience
Mesna is an organosulfur compound used as an adjuvant in cancer chemotherapy involving cyclophosphamide and ifosfamide. It is marketed as Uromitexan and Mesnex. The name of the substance is an acronym for 2-mercaptoethane sulfonate Na (Na being the chemical symbol for sodium).
On Jan, 6, 2016: 3,004 people reported to have side effects when taking Mesna. Among them, 40 people (1.33%) have Hallucination.
Time on Mesna when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 88.89% | 11.11% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Gender of people who have Hallucination when taking Mesna :
Female | Male | |
Hallucination | 51.22% | 48.78% |
Age of people who have Hallucination when taking Mesna :
0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
Hallucination | 0.00% | 4.00% | 32.00% | 0.00% | 32.00% | 0.00% | 4.00% | 28.00% |
On Jan, 6, 2016: 3,004 people reported to have side effects when taking Mesna. Among them, 47 people (1.56%) have Death.
Time on Mesna when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 50.00% | 10.00% | 0.00% | 0.00% | 0.00% | 40.00% | 0.00% |
Gender of people who have Death when taking Mesna :
Female | Male | |
Death | 47.83% | 52.17% |